Inactive

THIS REQUEST FOR INFORMATION (RFI) 36C26221Q0110 -IS ISSUED SOLELY FOR INFORMATION AND PLANNING PURPOSES ONLY AND DOES NOT CONSTITUTE A SOLICITATION. THE SUBMISSION OF PRICING, CAPABILITIES FOR PLANNI... THIS REQUEST FOR INFORMATION (RFI) 36C26221Q0110 -IS ISSUED SOLELY FOR INFORMATION AND PLANNING PURPOSES ONLY AND DOES NOT CONSTITUTE A SOLICITATION. THE SUBMISSION OF PRICING, CAPABILITIES FOR PLANNING PURPOSES, AND OTHER MARKET INFORMATION IS HIGHLY ENCOURAGED AND ALLOWED UNDER THIS RFI IN ACCORDANCE WITH (IAW) FAR 15.201(e). SOURCES SOUGHT DESCRIPTION This is NOT a solicitation announcement. This is a source sought/RFI for market research only. The purpose of this source sought/RFI is to gain knowledge of potential qualified sources and their size classification relative to NAICS 325412 (size standard is $1,250 Employees). Responses to this source sought will be used by the Government to make appropriate acquisition decisions. After review of the responses to this source sought, a solicitation announcement may be published. Responses to this source sought synopsis are not considered adequate responses for a solicitation announcement. The Department of Veterans Affairs (VA), VISN 22 Network Contracting Office, is seeking sources that can provide TOLVAPTAN 15M and 30M Pharmaceuticals that at a minimum meets the following salient characteristics in the Statement of Work for the VA Loma Linda Healthcare System: ITEM DESCRIPTION UNIT QUANTITY UNIT PRICE AMOUNT 0001 TOLVAPTAN 15MG TAB: 59148-0082-13 TOLVAPTAN 30MG TAB: 59148-0083-13 TOLVAPTAN 15MG X 7/45MG X 7 TAB,DOSEPACK,14: 59148-0087-28 TOLVAPTAN 30MG X 7/60MG X 7 TAB,DOSEPACK,14: 59148-0088-28 TOLVAPTAN 30MG X 7/90MG X 7 TAB,DOSEPACK,14: 59148-0089-28 EA 11   TOTAL  Include shipping cost on the items price. Vendor Requirements: Period of Performance is 11/14/2020 09/31/2021. Vendor shall quote all items under this requirement. Vendor shall meet all Salient Characteristics in the Statement of Work. Vendor must be the OEM, authorized distributor, or authorized reseller. Partnership letters will not be accepted. Vendor shall respond questions 1 through 8 of the Request of Information (RFI), see below. Salient Characteristics This requirement is to provide the oral selective vasopressin V2-receptor antagonist medication, tolvaptan (Jynarque), to the VA San Diego Healthcare system. Salient Characteristics The Vendor must be able to provide up to 11, 4 packs of following medication, equivalent to 28 tablets/month over the course of the contract period: Jynarque 15mg/45mg (NDC 59148-0087-28), Jynarque 30mg/60mg (NDC Vendor must be able to ensure and provide documentation that medications are handled appropriately per the manufacturer s specifications prior to the receipt of the medication by VA San Diego (i.e. maintained within 20°C - 25°C during storage and transportation). Medications must meet technical specifications stated in the FDA approved package. Medication must be stored and used in according with directions on the labeling. 59148-0088-28), Jynarque 30mg/90mg (NDC 59148-0089-28) Period of Performance 11/04/2020 09/30/2021 Vendor Requirements 3.1. Vendor shall provide all items under this requirement. Vendor shall meet all Salient Characteristics. Vendor must be the OEM, authorized distributor, or authorized reseller. Partnership letters will not be accepted. The information identified above is intended to be descriptive, not restrictive and to indicate the quality of the supplies/services that will be satisfactory. It is the responsibility of the interested source to demonstrate to the government that the interested parties can provide the supplies/services that fulfill the required specifications. If you are interested and are capable of providing the sought-out supplies/services, please provide the requested information as well as the information indicated below. Response to this notice should include company name, address, point of contact, size of business pursuant to the following questions: (1) Please indicates the size status and representations of your business, such as but not limited to: Service Disabled Veteran Owned Small Business (SDVOSB), Veteran Owned Small Business (VOSB), Hub zone, Woman Owned Small Business (WOSB), Large Business, etc.)? (2) Is your company considered small under the NAICS code identified under this RFI? (3) Are you the manufacturer or distributor of the items being referenced above (or equivalent product/solution)? What is the manufacturing country of origin of these items? (4) If you re a small business and you are an authorized distributor/reseller for the items identified above (or equivalent product/solution), do you alter; assemble; modify; the items requested in any way? If you do, state how and what is altered; assembled; modified? (5) Does your company have an FSS contract with GSA or the NAC or are you a contract holder with NASA SEWP or any other federal contract? If so, please provide the contract type and number. (6) If you are an FSS GSA/NAC or NASA SEWP contract holder or other federal contract holder, are the referenced items/solutions available on your schedule/contract? (7) Please provide general pricing for your products/solutions for market research purposes. (8) Please submit your capabilities in regard to the salient characteristics being provided and any information pertaining to equal to items to establish capabilities for planning purposes? *** Submissions addressing Section (8) should show clear, compelling and convincing*** evidence that all equal to items" meet all required salient characteristics. Responses to this notice shall be submitted via email to Mayra.Barbosa@va.gov. Telephone responses shall not be accepted. Responses must be received no later than 12 November 2020 at 8:00 AM PDT. If a solicitation is issued it shall be announced at a later date, and all interested parties must respond to that solicitation announcement separately from the responses to this request for information. Responses to this notice are not a request to be added to a prospective bidders list or to receive a copy of the solicitation. Please reference 36C26221Q0110, TOLVAPTAN 15M and 30M.